888

HUAKANG BIOMEDICAL HLDGS CO LTD

No trades
See on Supercharts
Market capitalization
‪46.95 M‬HKD
−0.015HKD
‪−6.39 M‬HKD
‪27.21 M‬HKD
‪145.54 M‬
Beta (1Y)
0.54

About HUAKANG BIOMEDICAL HLDGS CO LTD

CEO
Chun Guang Zhang
Headquarters
Kowloon
Employees (FY)
96
Founded
1992
ISIN
KYG4644W1069
FIGI
BBG00MPW9BD5
Huakang Biomedical Holdings Co. Ltd. operates as a medical group company. The firm engages in the manufacture and sale of in-vitro diagnostic (IVD) reagents in China. Its product portfolio of IVD reagents consists of male fertility IVD reagents, parasite antibody detection reagents and an EBV antibody detection reagent. The company was founded on August 3, 2017 and is headquartered in Hong Kong.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of 8622 is 0.095 HKD — it has decreased by 5.00% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on HKEX exchange HUAKANG BIOMEDICAL HLDGS CO LTD stocks are traded under the ticker 8622.
8622 stock is 7.53% volatile and has beta coefficient of 0.54. Check out the list of the most volatile stocks — is HUAKANG BIOMEDICAL HLDGS CO LTD there?
Yes, you can track HUAKANG BIOMEDICAL HLDGS CO LTD financials in yearly and quarterly reports right on TradingView.
8622 stock has fallen by 24.60% compared to the previous week, the month change is a 28.03% fall, over the last year HUAKANG BIOMEDICAL HLDGS CO LTD has showed a 39.10% decrease.
8622 net income for the last quarter is ‪−4.67 M‬ HKD, while the quarter before that showed ‪−1.65 M‬ HKD of net income which accounts for −184.08% change. Track more HUAKANG BIOMEDICAL HLDGS CO LTD financial stats to get the full picture.
Today HUAKANG BIOMEDICAL HLDGS CO LTD has the market capitalization of ‪46.95 M‬, it has increased by 5.93% over the last week.
No, 8622 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 8622 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade HUAKANG BIOMEDICAL HLDGS CO LTD stock right from TradingView charts — choose your broker and connect to your account.
8622 reached its all-time high on Dec 13, 2018 with the price of 0.540 HKD, and its all-time low was 0.091 HKD and was reached on Jun 17, 2020.
See other stocks reaching their highest and lowest prices.
As of Apr 20, 2024, the company has 96.00 employees. See our rating of the largest employees — is HUAKANG BIOMEDICAL HLDGS CO LTD on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So HUAKANG BIOMEDICAL HLDGS CO LTD technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating HUAKANG BIOMEDICAL HLDGS CO LTD stock shows the strong sell signal. See more of HUAKANG BIOMEDICAL HLDGS CO LTD technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. HUAKANG BIOMEDICAL HLDGS CO LTD EBITDA is ‪−3.85 M‬ HKD, and current EBITDA margin is −14.35%. See more stats in HUAKANG BIOMEDICAL HLDGS CO LTD financial statements.